M&T Bank Corp Has $447,000 Stock Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

M&T Bank Corp lessened its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 4.1% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,720 shares of the company’s stock after selling 632 shares during the quarter. M&T Bank Corp’s holdings in Acadia Healthcare were worth $447,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Treasurer of the State of North Carolina raised its stake in Acadia Healthcare by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 40,005 shares of the company’s stock valued at $1,586,000 after purchasing an additional 250 shares in the last quarter. Coldstream Capital Management Inc. raised its stake in Acadia Healthcare by 4.9% in the fourth quarter. Coldstream Capital Management Inc. now owns 6,470 shares of the company’s stock valued at $257,000 after purchasing an additional 303 shares in the last quarter. Covestor Ltd raised its stake in Acadia Healthcare by 27.2% in the fourth quarter. Covestor Ltd now owns 1,450 shares of the company’s stock valued at $58,000 after purchasing an additional 310 shares in the last quarter. Xponance Inc. raised its stake in Acadia Healthcare by 5.9% in the fourth quarter. Xponance Inc. now owns 10,530 shares of the company’s stock valued at $418,000 after purchasing an additional 590 shares in the last quarter. Finally, Quantinno Capital Management LP raised its stake in Acadia Healthcare by 9.0% in the fourth quarter. Quantinno Capital Management LP now owns 8,695 shares of the company’s stock valued at $345,000 after purchasing an additional 721 shares in the last quarter.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $22.68 on Thursday. The stock has a market cap of $2.09 billion, a P/E ratio of 11.17, a price-to-earnings-growth ratio of 4.43 and a beta of 0.93. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.72. The stock’s 50-day moving average is $23.14 and its 200-day moving average is $30.43. Acadia Healthcare Company, Inc. has a 1-year low of $20.36 and a 1-year high of $82.41.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to analysts’ expectations of $769.90 million. Acadia Healthcare had a return on equity of 8.72% and a net margin of 5.94%. The business’s quarterly revenue was up .3% compared to the same quarter last year. During the same period in the previous year, the business posted $0.84 earnings per share. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analyst Ratings Changes

ACHC has been the subject of a number of analyst reports. Guggenheim began coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $36.00 price target for the company. Barclays decreased their target price on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a research report on Wednesday, May 14th. Stephens upgraded Acadia Healthcare to a “hold” rating in a research report on Monday, June 2nd. KeyCorp decreased their target price on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Finally, Wall Street Zen upgraded Acadia Healthcare from a “sell” rating to a “hold” rating in a research report on Thursday, May 22nd. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.